These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10969586)

  • 21. New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
    Goss P; Allan AL; Rodenhiser DI; Foster PJ; Chambers AF
    APMIS; 2008; 116(7-8):552-68. PubMed ID: 18834402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Minimal residual disease in breast cancer: detection and clinical relevance].
    Pantel K; Wölfle U
    Verh Dtsch Ges Pathol; 2005; 89():68-75. PubMed ID: 18035675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-vascular interactions and tumor dormancy.
    Naumov GN; Folkman J; Straume O; Akslen LA
    APMIS; 2008; 116(7-8):569-85. PubMed ID: 18834403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
    Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
    Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of minimal residual disease in patients with cancer: a review of techniques, clinical implications, and emerging therapeutic consequences.
    Köstler WJ; Brodowicz T; Hejna M; Wiltschke C; Zielinski CC
    Cancer Detect Prev; 2000; 24(4):376-403. PubMed ID: 11059569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corrupt policemen: inflammatory cells promote tumor angiogenesis.
    Zumsteg A; Christofori G
    Curr Opin Oncol; 2009 Jan; 21(1):60-70. PubMed ID: 19125020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dormant tumors and organs resistant to metastasis after gene transfer: dream and reality of anti-angiogenic gene therapy].
    Li H; Dkhissi F; Grenet C; Soria C; Lu H
    Therapie; 2001; 56(5):501-10. PubMed ID: 11806286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Micrometastases in pediatric oncology].
    Bernard F; Aerts I; Margueritte G; Astruc J
    Bull Cancer; 2001 Jun; 88(6):577-80. PubMed ID: 11459704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
    Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
    Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintenance therapy to suppress micrometastasis: the new challenge for adjuvant cancer treatment.
    Epstein RJ
    Clin Cancer Res; 2005 Aug; 11(15):5337-41. PubMed ID: 16061845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological significance of isolated tumor cells and micrometastasis in lymph nodes evaluated using a green fluorescent protein-tagged human gastric cancer cell line.
    Yokoyama H; Nakanishi H; Kodera Y; Ikehara Y; Ohashi N; Ito Y; Koike M; Fujiwara M; Tatematsu M; Nakao A
    Clin Cancer Res; 2006 Jan; 12(2):361-8. PubMed ID: 16428473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Minimal residual disease in gastrointestinal tumors: tumor detection in bone marrow, blood and lymph nodes].
    Rosenberg R; Nekarda H; Thorban S; Siewert JR
    Acta Med Austriaca Suppl; 2002; 59():42-53. PubMed ID: 12506760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling growth kinetics and statistical distribution of oligometastases.
    Withers HR; Lee SP
    Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The DARC side of metastasis: shining a light on KAI1-mediated metastasis suppression in the vascular tunnel.
    Zijlstra A; Quigley JP
    Cancer Cell; 2006 Sep; 10(3):177-8. PubMed ID: 16959609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers in cancer micrometastasis: where are we at?
    Gerges N; Jabado N
    Bioanalysis; 2010 May; 2(5):881-99. PubMed ID: 21083219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of metastasis.
    Springfield DS
    Clin Orthop Relat Res; 1982 Sep; (169):15-9. PubMed ID: 7105570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status in human breast cancer micrometastasis.
    Alix-Panabières C; Müller V; Pantel K
    Curr Opin Oncol; 2007 Nov; 19(6):558-63. PubMed ID: 17906452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the organ microenvironment in the biology and therapy of cancer metastasis.
    Fidler IJ; Kim SJ; Langley RR
    J Cell Biochem; 2007 Jul; 101(4):927-36. PubMed ID: 17177290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of angiogenesis in the growth and progression of tumors. Treatment with angiogenesis inhibitors: from promising results in experimental animal models to the reality of clinical use].
    Plavetić ND; Letilović T; Vrbanec D
    Lijec Vjesn; 2003; 125(9-10):260-5. PubMed ID: 15038217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.